Milena Salerno

1.0k total citations
37 papers, 898 citations indexed

About

Milena Salerno is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Milena Salerno has authored 37 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Molecular Biology and 12 papers in Infectious Diseases. Recurrent topics in Milena Salerno's work include Drug Transport and Resistance Mechanisms (23 papers), HIV/AIDS drug development and treatment (12 papers) and Metal complexes synthesis and properties (9 papers). Milena Salerno is often cited by papers focused on Drug Transport and Resistance Mechanisms (23 papers), HIV/AIDS drug development and treatment (12 papers) and Metal complexes synthesis and properties (9 papers). Milena Salerno collaborates with scholars based in France, Italy and Brazil. Milena Salerno's co-authors include Arlette Garnier‐Suillerot, Carole Marbeuf‐Gueye, Henryk Kozłowski, María Novella Romanelli, Dina Manetti, Elisabetta Teodori, Silvia Dei, Waldemar Priebe, Magdalena Rowińska‐Żyrek and Marcella Coronnello and has published in prestigious journals such as Coordination Chemistry Reviews, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Milena Salerno

36 papers receiving 888 citations

Peers

Milena Salerno
Anand Balakrishnan United States
Rémy Kachadourian United States
Avner Ramu Israel
Olafur Gudmundsson United States
Deep Kwatra United States
William J. Ehlhardt United States
Anand Balakrishnan United States
Milena Salerno
Citations per year, relative to Milena Salerno Milena Salerno (= 1×) peers Anand Balakrishnan

Countries citing papers authored by Milena Salerno

Since Specialization
Citations

This map shows the geographic impact of Milena Salerno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milena Salerno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milena Salerno more than expected).

Fields of papers citing papers by Milena Salerno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milena Salerno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milena Salerno. The network helps show where Milena Salerno may publish in the future.

Co-authorship network of co-authors of Milena Salerno

This figure shows the co-authorship network connecting the top 25 collaborators of Milena Salerno. A scholar is included among the top collaborators of Milena Salerno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milena Salerno. Milena Salerno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gumienna‐Kontecka, Elżbieta, Henryk Kozłowski, Maryline Beyler, et al.. (2023). Multistep synthesis of a novel copper complex with potential for Alzheimer’s disease diagnosis. JBIC Journal of Biological Inorganic Chemistry. 28(8). 777–790. 2 indexed citations
2.
Dei, Silvia, Marcella Coronnello, Gianluca Bartolucci, et al.. (2018). Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents. European Journal of Medicinal Chemistry. 147. 7–20. 16 indexed citations
3.
Teodori, Elisabetta, Silvia Dei, Marcella Coronnello, et al.. (2017). N -alkanol- N -cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy. European Journal of Medicinal Chemistry. 127. 586–598. 12 indexed citations
4.
Salerno, Milena, et al.. (2015). Evidence against a role of P-glycoprotein in the clearance of the Alzheimer’s disease Aβ1–42 peptides. Cell Stress and Chaperones. 20(3). 421–430. 10 indexed citations
5.
Djaker, Nadia, Sanda Boca, Milena Salerno, et al.. (2015). Comparative toxicity evaluation of flower-shaped and spherical gold nanoparticles on human endothelial cells. Nanotechnology. 26(5). 55101–55101. 53 indexed citations
6.
Dei, Silvia, Marcella Coronnello, Gianluca Bartolucci, et al.. (2014). Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters. European Journal of Medicinal Chemistry. 87. 398–412. 22 indexed citations
7.
Orlandi, Francesca, Marcella Coronnello, Cristina Bellucci, et al.. (2012). New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR). Bioorganic & Medicinal Chemistry. 21(2). 456–465. 15 indexed citations
8.
Lambert, Catherine, Heloísa Beraldo, N. Lièvre, et al.. (2012). Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation. JBIC Journal of Biological Inorganic Chemistry. 18(1). 59–69. 13 indexed citations
9.
Garnier‐Suillerot, Arlette, et al.. (2009). Accumulation of Eu3+ chelates in cells expressing or not P-glycoprotein: Implications for blood–brain barrier crossing. Journal of Inorganic Biochemistry. 104(1). 47–54. 8 indexed citations
10.
García-Marchán, Yael, et al.. (2009). Trypanosoma cruzi calmodulin: Cloning, expression and characterization. Experimental Parasitology. 123(4). 326–333. 9 indexed citations
11.
Salerno, Milena, et al.. (2008). Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells. JBIC Journal of Biological Inorganic Chemistry. 14(1). 123–132. 13 indexed citations
12.
Frézard, Fréderic, Patricia Silveira Martins, Laurence Le Moyec, et al.. (2007). Enhanced oral delivery of antimony from meglumine antimoniate/β-cyclodextrin nanoassemblies. International Journal of Pharmaceutics. 347(1-2). 102–108. 26 indexed citations
13.
Salerno, Milena, D. Adès, Alain Siove, et al.. (2007). Ability of carbazole salts, inhibitors of Alzheimer β-amyloid fibril formation, to cross cellular membranes. European Journal of Pharmacology. 559(2-3). 124–131. 24 indexed citations
15.
Garnier‐Suillerot, Arlette, et al.. (2006). Mechanism of thioflavin T accumulation inside cells overexpressing P-glycoprotein or multidrug resistance-associated protein: Role of lipophilicity and positive charge. Biochemical and Biophysical Research Communications. 343(2). 623–629. 36 indexed citations
16.
Salerno, Milena, et al.. (2003). New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA. Chemico-Biological Interactions. 145(3). 349–358. 38 indexed citations
17.
Salerno, Milena & Arlette Garnier‐Suillerot. (2003). Resistance to Arsenic‐ and Antimony‐Based Drugs. Bioinorganic Chemistry and Applications. 1(2). 189–198. 9 indexed citations
18.
Salerno, Milena, et al.. (2002). The MRP1-Mediated Effluxes of Arsenic and Antimony Do Not Require Arsenic–Glutathione and Antimony–Glutathione Complex Formation. Journal of Bioenergetics and Biomembranes. 34(2). 135–145. 37 indexed citations
19.
Salerno, Milena, Teresa Przewloka, Izabela Fokt, Waldemar Priebe, & Arlette Garnier‐Suillerot. (2002). Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine. Biochemical Pharmacology. 63(8). 1471–1479. 13 indexed citations
20.
Marbeuf‐Gueye, Carole, et al.. (2000). Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. European Journal of Pharmacology. 391(3). 207–216. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026